Showing results (191-200 of 203) with videos related to
Sort By:
Pageof 21
American Journal of Hematology|November 1, 1988
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working groupB D Cheson, J M Bennett, K R Rai, et al.Blood|July 1, 1994
HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3A A Scott, D R Head, K J Kopecky, et al.Blood|July 27, 1999
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group StudyC P Leith, K J Kopecky, I M Chen, et al.Leukemia|April 30, 2004
The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cellsD M Lucas, M E Davis, M R Parthun, et al.Leukemia|February 25, 2015
Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemiaJ Flynn, J Jones, A J Johnson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemiaS D Gore, E K Rowinsky, C B Miller, et al.Blood|October 26, 2000
Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatinI W Flinn, K J Kopecky, M K Foucar, et al.Leukemia|May 25, 2011
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridolK A Blum, A S Ruppert, J A Woyach, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicityJ C Byrd, T Murphy, R S Howard, et al.Leukemia|February 20, 2003
Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cellsM I Klisovic, E A Maghraby, M R Parthun, et al.Pageof 21